Nucleotide phosphoramidates as anticancer agents
Details for Australian Patent Application No. 2004261455 (hide)
International Classifications
Event Publications
8 September 2005 PCT application entered the National Phase
PCT publication WO2005/012327 Priority application(s): WO2005/012327
9 October 2008 Assignment before Grant
University College Cardiff Consultants Limited The application has been assigned to Cardiff Protides Limited
23 December 2010 Application Accepted
Published as AU-B-2004261455
21 April 2011 Standard Patent Sealed
30 June 2011 Licence Registered
Cardiff Protides Limited ( NuCana BioMed Limited )
5 July 2012 Assignment Registered
Cardiff Protides Limited The patent has been assigned to Nucana Biomed Limited
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004261453-Synthetic method for the preparation of quinazolin-4-one derivative
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser